» Articles » PMID: 35104170

Overexpression of Eukaryotic Translation Initiation Factor 3D Induces Stem Cell-like Properties and Metastasis in Cervix Cancer by Activating FAK Through Inhibiting Degradation of GRP78

Overview
Journal Bioengineered
Date 2022 Feb 1
PMID 35104170
Authors
Affiliations
Soon will be listed here.
Abstract

Cervix cancer (CC) is the most common gynecological malignancy and the leading cause of morbidity among women worldwide. Previous study indicated that cancer stem cells (CSCs) existed in cervix cancer, and suppressing CSC characteristics of cervix cancer is needed to combat this disease. Eukaryotic translation initiation factor 3 (EIF3) is one of the most complex eukaryotic translation initiation factors containing 13 subunits (EIF3A-EIF3M) and it regulates eukaryotic translation. One member of EIF3, EIF3D, plays a role in the progression and development of multiple tumors. However, its possible role in cervix cancer progression is still unclear. In this study, we found the high EIF3D expression in human cervix cancer tissues. We further found that downregulation of EIF3D suppressed the proliferation and motility of cervix cancer cells. Furthermore, its downregulation restrained the stem cell-like properties of cervix cancer cells. Mechanically, we found that EIF3D promoted FAK activation through GRP78 in cervix cancer cells, thus contributing to the progression of cervix cancer. Therefore our results suggested that EIF3D could serve as a promising target of cervix cancer.

Citing Articles

Integrative analysis of m7G methylation-associated genes prognostic signature with immunotherapy and identification of LARP1 as a key oncogene in head and neck squamous cell carcinoma.

Xu J, You Z, Zhu Z, Liu M, Zhang Z, Xu P Front Immunol. 2025; 16:1520070.

PMID: 40018039 PMC: 11864954. DOI: 10.3389/fimmu.2025.1520070.


GRP78 as a potential therapeutic target in cancer treatment: an updated review of its role in chemoradiotherapy resistance of cancer cells.

Lin M, Mo Y, Li C, Liu Y, Feng X Med Oncol. 2025; 42(2):49.

PMID: 39827214 DOI: 10.1007/s12032-024-02586-0.


Ribosomal rodeo: wrangling translational machinery in gynecologic tumors.

Filipek K, Penzo M Cancer Metastasis Rev. 2024; 44(1):13.

PMID: 39621173 PMC: 11611960. DOI: 10.1007/s10555-024-10234-2.


Deciphering EIF3D's Role in Immune Regulation and Malignant Progression: A Pan-Cancer Analysis with a Focus on Colon Adenocarcinoma.

Zhou Y, Chai R, Wang Y, Yu X J Inflamm Res. 2024; 17:6847-6862.

PMID: 39372593 PMC: 11451429. DOI: 10.2147/JIR.S469948.


Predictive Value and Immunological Role of the HSPA5 Gene in Cervical Cancer.

Bai Y, Miao Y, Wang J, Gan J, Feng J Biochem Genet. 2024; .

PMID: 38584219 DOI: 10.1007/s10528-024-10782-w.


References
1.
Kang Y, Yoon S, Park B . Allergen‑removed Rhus verniciflua Stokes suppresses invasion and migration of pancreatic cancer cells through downregulation of the JAK/STAT and Src/FAK signaling pathways. Oncol Rep. 2018; 40(5):3060-3068. DOI: 10.3892/or.2018.6699. View

2.
Jang H, Bak Y, Pham T, Kwon S, Kim B, Hong J . STK899704 inhibits stemness of cancer stem cells and migration via the FAK-MEK-ERK pathway in HT29 cells. BMB Rep. 2018; 51(11):596-601. PMC: 6283024. View

3.
Atarashi H, Jayasinghe W, Kwon J, Kim H, Taninaka Y, Igarashi M . Artificially Edited Alleles of the Eukaryotic Translation Initiation Factor 4E1 Gene Differentially Reduce Susceptibility to Cucumber Mosaic Virus and Potato Virus Y in Tomato. Front Microbiol. 2020; 11:564310. PMC: 7758215. DOI: 10.3389/fmicb.2020.564310. View

4.
Li B, Cheng X, Yang Y, Li Z . GRP78 mediates radiation resistance of a stem cell-like subpopulation within the MCF-7 breast cancer cell line. Oncol Rep. 2013; 30(5):2119-26. DOI: 10.3892/or.2013.2710. View

5.
Pan X, Chen L, Hong Y, Xu D, Liu X, Li L . EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling. Int J Oncol. 2016; 48(6):2580-90. DOI: 10.3892/ijo.2016.3459. View